The (Re)new Way

Through collaboration with healthcare and industry leaders, we strive to equip researchers and providers with genomic and epigenomic tools that enhance decision-making and ultimately improve patient outcomes. Committed to revolutionizing clinical diagnostics, we launch specialized biotech companies, each dedicated to transforming healthcare one breakthrough at a time.

Meet Our Leadership

Founded by experts in genetics, epigenetics, and bioinformatics, we are at the forefront of innovation, driving groundbreaking research and development from its inception.

CEO

Chad Pollard

› Linkedin

VP of R&D

Tim
Jenkins

› Linkedin

COO

Steven Abott

› Linkedin

CFO

Adam Hewlett

› Linkedin

Business Advisor + Investor

Garrett
Fuller

› Linkedin

Legal Advisor + Investor

Brad Randall

› Linkedin

The PeoplE

Portfolio Highlights

› Founder of Wasatch Biolabs

Jonathon Hill

“Wasatch Biolabs is leading a paradigm shift in the way we acquire, analyze, and apply DNA sequencing to research, diagnostics, and precision medicine."

We’ve developed innovative DNA sequencing-based solutions to address significant technology gaps we’ve identified within research and diagnostic medicine. We’re excited to see how they impact the field and fuel innovation.”

› Founder of exxperts

Kelaney Stalker

“It wasn’t until 1993 that Congress passed a law requiring the inclusion of women and minorities in clinical research."

Our goal is to develop tools to better understand, diagnose, treat, and monitor conditions that disproportionately affect women. Beginning with a forensics test to distinguish menstrual from peripheral blood and a blood test to detect biomarkers of endometriosis, Exxperts is dedicated to advancing women’s health—for women, by women.

› Founder of Pathogen

Ethan McQuhae

“Diagnostic delays and uncertainty are far too common for many bacterial infections. Pathogen is revolutionizing this diagnostic landscape."

Our flagship Lyme Disease test promises rapid and accurate detection of DNA from B. burgdorferi and other Lyme Disease-causing bacteria. By providing more effective diagnostic tools, Pathogen offers hope and relief to those overlooked by current methods. We are excited to transform healthcare for pathogen infections.

The (Re)new Way

Meet Our Leadership

Chad Pollard

TimJenkins

Steven Abott

Adam Hewlett

GarrettFuller

Brad Randall

Portfolio Highlights

Jonathon Hill

“Wasatch Biolabs is leading a paradigm shift in the way we acquire, analyze, and apply DNA sequencing to research, diagnostics, and precision medicine."

Kelaney Stalker

“It wasn’t until 1993 that Congress passed a law requiring the inclusion of women and minorities in clinical research."

Ethan McQuhae

“Diagnostic delays and uncertainty are far too common for many bacterial infections. Pathogen is revolutionizing this diagnostic landscape."

Tim
Jenkins

Garrett
Fuller